Mariner
BME icon

Mariner’s BlackRock Health Sciences Trust BME Stock Holding History

Mariner’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,332
Closed -$257K – 2912
2023
Q2 		$257K Buy
6,332
+880
+16% +$36.2K ﹤0.01% 2244
2023
Q1 		$228K Buy
+5,452
New +$229K ﹤0.01% 2300

Other funds holding BME

NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Mariner's BME Position: Q3 2023 in Review

Mariner sold out of BlackRock Health Sciences Trust (BME) in Q3 2023, closing a stake of 6,332 shares — an estimated $257K sold.

Mariner first reported a position in BME in Q1 2023 and held it in 2 quarters. The position peaked at $257K in Q2 2023. 72 funds tracked by Wall St. Rank hold BME as of Q3 2023.

  • Mariner reported no remaining BlackRock Health Sciences Trust position as of Q3 2023 after selling out during the quarter.
  • Mariner sold 6,332 BlackRock Health Sciences Trust shares in Q3 2023, an estimated $257K.
  • Mariner first reported a position in BlackRock Health Sciences Trust in Q1 2023 and held it in 2 quarters.
  • Mariner's BlackRock Health Sciences Trust position peaked at $257K in Q2 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2023.

Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.